Menu
Fechar
HRS4R
Vull donar
Firma
ARANTXA ERASO-URIÉN
Posició
Cap de Grup - R4
Caps de Grup - R4
Projectes
Publicacions

Projectes

Genètica Cardiovascular

Impacto de un programa estructurado de ejercicio físico y control de factores de riesgo cardiovasculares en prevención primaria de cardiotoxicidad en pacientes con cáncer de mama sometidos a tratamientos cardiotóxicos: Estudio PREV

Codi oficial: Estudio PREV Data inici: 01/11/2021 Data fi: 31/12/2025 Investigador/a principal: ARANTXA ERASO URIÉN, SERGI MORAL TORRES Organisme finançador: FUNDACION MERCK SALUD
Oncologia Radioteràpica i Física Mèdica de Girona

Linfadenectomía axilar versus radioterapia axilar en pacientes con ganglio centinela positivo tras terapia neodyuvante. Estudio multicéntrico randomizado fase III.

Codi oficial: ADARNAT I Data inici: 09/12/2022 Data fi: 09/12/2027 Investigador/a principal: LUIS MIGUEL ALONSO RUANO, ARANTXA ERASO URIÉN Organisme finançador: ASSOCIACIÓ ESPANYOLA CONTRA EL CÀNCER

Publicacions

Pla H, Fullana B, Esteve A, Fort-Culillas R, Ferrando-Díez A, Fernández-Ortega A, Pous A, Stradella A, Villanueva-Vázquez R, Cirauqui B, Falo C, Martínez-Pérez E, Molina G, Del Barco S, Eraso A, Margelí M, Viñas G, Gil-Gil M, Petriz L, Pernas S

Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d'Oncologia Breast Cancer Observational Cohort Study.

Cancers, 2025, 17 dx.doi.org/10.3390/cancers17081366
Romera-Martínez I, Cancio IO, Buxó M, Martínez J, Fuentes-Raspall R, Urién AE, Vilanova JC

Heart substructure exposure during left breast cancer radiotherapy: a dosimetric comparison between hybrid VMAT and 3DCRT in free breathing and deep inspiration breath hold (DIBH).

CLINICAL & TRANSLATIONAL ONCOLOGY, 2025 dx.doi.org/10.1007/s12094-025-03943-9
Marruecos Querol J, Jurado-Bruggeman D, Lopez-Vidal A, Mesía Nin R, Rubió-Casadevall J, Buxó M, Eraso Urien A

Contouring aid tools in radiotherapy. Smoothing: the false friend

CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26, 1956-1967 dx.doi.org/10.1007/s12094-024-03420-9
Corral J, Algara M, Muñoz-Montplet C, Eraso A, Giralt J, Defourny N, Lievens Y, Borras JM

Challenges in assessing national radiotherapy costs: application of the ESTRO-HERO model in Spain.

Frontiers in Public Health, 2024, 12, 1474376-1474376 dx.doi.org/10.3389/fpubh.2024.1474376
Romera-Mart nez, I, Oliveras, I, Bux , M, Mart nez, J, Raspall, RF, Urien, AE, Nadal, EP, Vilanova, JC

DOSIMETRIC COMPARISON OF HEART SUBSTRUCTURES FOR DIBH BETWEEN FREE BREATHING FOR BREAST CANCER

RADIOTHERAPY AND ONCOLOGY, 2024, 194, 640-641
Sanz, CA, Romera-Mart nez, I, Jurado-Bruggeman, D, Urien, AE, Raspall, RF

Radiotherapy for gastric lymphoma. A proposal for improving treatment delivery and reproducibility

RADIOTHERAPY AND ONCOLOGY, 2024, 194, 1168-1170
Mu oz-Montplet, C, Jurado-Bruggeman, D, Eraso, A, Fuentes-Raspall, R

The Impact of Advanced Algorithms on the Treatment of Meningiomas

RADIOTHERAPY AND ONCOLOGY, 2024, 194, 3452-3454
Bonet, M, Recalde, E, Soto, A, Martinez, A, Murcia, M, Mases, J, Fernandez, MN, Yufera, JC, Alvarez, A, Eraso, MA, Feltes, N, Hernandez, L, Bernard, P, Ramos, L, Garcia, V

Use of social media in radiation oncology: multicenter data from the GOCO Group

Reports of Practical Oncology and Radiotherapy, 2024, 29, 236-244 dx.doi.org/10.5603/rpor.100386
Sais, E, PLUJA, A., MONTAÑES, C., Bujons-Buscarons, E, PINEDA, F., Iguaran A, Roselló À, Hernández Martínez A, Teixidor-Vilà, E, ROMERA, A., Bosch-Barrera, J, ERASO, A., Oliva-Poch E

1062P Effect of the immunological circadian rhythm on the treatment of locally advanced non-small cell lung cancer treated with consolidation immunotherapy

ANNALS OF ONCOLOGY, 2024, 35, 1-1 dx.doi.org/10.1016/j.annonc.2024.08.1120
Marruecos-Querol J, Rubió-Casadevall J, Lozano A, Buxó M, Puigdemont M, Linares I, Planas I, Vayreda J, Cirauqui B, Taberna M, Quiroga V, Tobed M, Borés A, Recalde S, Saigi M, Felip E, Eraso A, Mesía R

Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25, 2384-2392 dx.doi.org/10.1007/s12094-023-03121-9

Formulari de contacte

Coneix l’IDIBGI!

 menu